| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Acquired Resistance to Targeted Therapies Against Oncogene-Driven Non–Small-Cell Lung Cancer: Approach to Subtyping Progressive Disease and Clinical Implications
|
Gandara, David R.
|
|
2014
|
15 |
1 |
p. 1-6
6 p.
|
article
|
| 2 |
Altered Glutamine Metabolism and Therapeutic Opportunities for Lung Cancer
|
Mohamed, Amr
|
|
2014
|
15 |
1 |
p. 7-15
9 p.
|
article
|
| 3 |
A Phase II Trial of Saracatinib, an Inhibitor of src Kinases, in Previously-Treated Advanced Non–Small-Cell Lung Cancer: The Princess Margaret Hospital Phase II Consortium
|
Laurie, Scott A.
|
|
2014
|
15 |
1 |
p. 52-57
6 p.
|
article
|
| 4 |
A Tabulated Summary of Targeted and Biologic Therapies for Non–Small-Cell Lung Cancer
|
Simon, George R.
|
|
2014
|
15 |
1 |
p. 21-51
31 p.
|
article
|
| 5 |
Clinical Outcome With Platinum-Based Chemotherapy in Patients With Advanced Nonsquamous EGFR Wild-Type Non–Small-Cell Lung Cancer Segregated According to KRAS Mutation Status
|
Metro, Giulio
|
|
2014
|
15 |
1 |
p. 86-92
7 p.
|
article
|
| 6 |
Editorial Board
|
|
|
2014
|
15 |
1 |
p. A1-
1 p.
|
article
|
| 7 |
High Coexpression of Both EGFR and IGF1R Correlates With Poor Patient Prognosis in Resected Non–Small-Cell Lung Cancer
|
Gately, Kathy
|
|
2014
|
15 |
1 |
p. 58-66
9 p.
|
article
|
| 8 |
Novel Association Between CD74 Polymorphisms and Hematologic Toxicity in Patients With NSCLC After Platinum-Based Chemotherapy
|
Tan, Xiaoming
|
|
2014
|
15 |
1 |
p. 67-78.e12
7.7999999999934E13 p.
|
article
|
| 9 |
Stage Migration in Planning PET/CT Scans in Patients Due to Receive Radiotherapy for Non–Small-Cell Lung Cancer
|
Geiger, Geoffrey A.
|
|
2014
|
15 |
1 |
p. 79-85
7 p.
|
article
|
| 10 |
Summary Report From the 13th Annual Targeted Therapies of the Treatment of Lung Cancer Meeting
|
Morgensztern, Daniel
|
|
2014
|
15 |
1 |
p. 16-20
5 p.
|
article
|
| 11 |
Table of Contents
|
|
|
2014
|
15 |
1 |
p. A2-A3
nvt p.
|
article
|
Journal description